Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Association between hepatitis C virus and chronic kidney disease: heterogeneity begets heterogeneity.

Lucas GM.

Kidney Int. 2017 Sep;92(3):546-548. doi: 10.1016/j.kint.2017.04.023.

PMID:
28807261
2.

Rhabdomyolysis in an HIV cohort: epidemiology, causes and outcomes.

Koubar SH, Estrella MM, Warrier R, Moore RD, Lucas GM, Atta MG, Fine DM.

BMC Nephrol. 2017 Jul 17;18(1):242. doi: 10.1186/s12882-017-0656-9.

3.

Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial.

Achhra AC, Mocroft A, Ross M, Ryom-Nielson L, Avihingsanon A, Bakowska E, Belloso W, Clarke A, Furrer H, Lucas GM, Ristola M, Rassool M, Ross J, Somboonwit C, Sharma S, Wyatt C.

Int J Antimicrob Agents. 2017 Sep;50(3):453-460. doi: 10.1016/j.ijantimicag.2017.04.021. Epub 2017 Jun 28.

PMID:
28668686
4.

Injection Drug Network Characteristics Are Important Markers of HIV Risk Behavior and Lack of Viral Suppression.

Cepeda JA, Solomon SS, Srikrishnan AK, McFall AM, Kumar MS, Vasudevan CK, Anand S, Celentano DD, Lucas GM, Mehta SH.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):257-264. doi: 10.1097/QAI.0000000000001372.

PMID:
28328550
5.

Longitudinal Assessment of Proximal Tubular Dysfunction in HIV Seropositive and Seronegative Persons: Correlates and Implications.

Sheets KM, Atta MG, Fine DM, Zook K, Mcfall AM, Estrella MM, Schwartz GJ, Lucas GM.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):45-51. doi: 10.1097/QAI.0000000000001302.

PMID:
28151777
6.

Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India.

Sabri B, McFall AM, Solomon SS, Srikrishnan AK, Vasudevan CK, Anand S, Celentano DD, Mehta SH, Kumar S, Lucas GM.

PLoS One. 2017 Jan 18;12(1):e0169482. doi: 10.1371/journal.pone.0169482. eCollection 2017.

7.
8.

HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease.

Lucas GM, Atta MG, Fine DM, McFall AM, Estrella MM, Zook K, Stein JH.

Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2100-7. doi: 10.1161/ATVBAHA.116.307985. Epub 2016 Sep 8.

9.

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C.

JAMA. 2016 Jul 12;316(2):156-70. doi: 10.1001/jama.2016.8914.

10.

Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals.

Atta MG, Estrella MM, Fine DM, Zook K, Monroy Trujillo JM, Stein JH, Lucas GM.

PLoS One. 2016 May 13;11(5):e0155312. doi: 10.1371/journal.pone.0155312. eCollection 2016.

11.

Getting to 90: linkage to HIV care among men who have sex with men and people who inject drugs in India.

McFall AM, Mehta SH, Srikrishnan AK, Lucas GM, Vasudevan CK, Celentano DD, Kumar MS, Solomon S, Solomon SS.

AIDS Care. 2016 Oct;28(10):1230-9. doi: 10.1080/09540121.2016.1168915. Epub 2016 Apr 7.

12.

Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

Solomon SS, Mehta SH, McFall AM, Srikrishnan AK, Saravanan S, Laeyendecker O, Balakrishnan P, Celentano DD, Solomon S, Lucas GM.

Lancet HIV. 2016 Apr;3(4):e183-90. doi: 10.1016/S2352-3018(16)00019-9. Epub 2016 Mar 11.

13.

Validity and utility of monopolar spinal cord stimulation in pediatric scoliosis surgery.

Gomes C, Kuchenbuch M, Lucas G, Argaud S, Violas P, Sauleau P.

Eur Spine J. 2016 Oct;25(10):3201-3207. Epub 2016 Mar 8.

PMID:
26957100
14.

Effects of field storage method on E. coli concentrations measured in storm water runoff.

Harmel D, Wagner K, Martin E, Smith D, Wanjugi P, Gentry T, Gregory L, Hendon T.

Environ Monit Assess. 2016 Mar;188(3):170. doi: 10.1007/s10661-016-5183-9. Epub 2016 Feb 16.

PMID:
26884357
15.

Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.

Atta MG, Estrella MM, Skorecki KL, Kopp JB, Winkler CA, Wasser WG, Shemer R, Racusen LC, Kuperman M, Foy MC, Lucas GM, Fine DM.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):262-70. doi: 10.2215/CJN.07490715. Epub 2015 Dec 14.

16.

Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.

Lucas GM, Atta MG, Zook K, McFall AM, Mehta SH, Fine DM, Stein JH, Schwartz GJ.

AIDS. 2016 Feb 20;30(4):619-26. doi: 10.1097/QAD.0000000000000949.

17.

Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.

Waheed S, Attia D, Estrella MM, Zafar Y, Atta MG, Lucas GM, Fine DM.

Clin Kidney J. 2015 Aug;8(4):420-5. doi: 10.1093/ckj/sfv041. Epub 2015 Jun 3.

18.

HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement.

Mehta SH, Lucas GM, Solomon S, Srikrishnan AK, McFall AM, Dhingra N, Nandagopal P, Kumar MS, Celentano DD, Solomon SS.

Clin Infect Dis. 2015 Dec 1;61(11):1732-41. doi: 10.1093/cid/civ669. Epub 2015 Aug 6.

19.

Vertebroplasty for vertebral hemangioma in children: a report of two cases with 2-year follow-up.

Issa M, Lucas G, Violas P, Griffet J, Courvoisier A.

Childs Nerv Syst. 2015 Nov;31(11):2179-83. doi: 10.1007/s00381-015-2777-4. Epub 2015 Jun 13.

PMID:
26070966
20.

Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy.

Waheed S, Sakr A, Chheda ND, Lucas GM, Estrella M, Fine DM, Atta MG.

PLoS One. 2015 Jun 10;10(6):e0129702. doi: 10.1371/journal.pone.0129702. eCollection 2015.

Supplemental Content

Loading ...
Support Center